BioRegenx, Inc. (BRGX)
OTCMKTS · Delayed Price · Currency is USD
0.0076
0.00 (0.00%)
Jun 25, 2026, 10:03 AM EST
BioRegenx Market Cap
BioRegenx has a market cap or net worth of $8.94 million as of June 26, 2026. Its market cap has decreased by -41.60% in one year.
Market Cap
8.94M
Enterprise Value
11.06M
Revenue
1.77M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.01
Market Cap Chart
Since March 12, 2024, BioRegenx's market cap has decreased from 49.89M to 8.94M, a decrease of -82.08%. That is a compound annual growth rate of -52.80%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2026 | 8.94M | -27.97% |
| Dec 31, 2025 | 12.41M | 44.15% |
| Dec 31, 2024 | 8.61M | -82.74% |
| Mar 12, 2024 | 49.89M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Vaso Corporation | 33.44M |
| Healixa | 29.43M |
| Retrieve Medical Holdings | 25.81M |
| Pharma-Bio Serv | 12.94M |
| PreAxia Health Care Payment Systems | 9.47M |
| CompuMed | 7.93M |
| Vynleads | 7.51M |
| Welsis | 6.85M |